Skip to content
10-Q

Quarterly Report

BIOTRICITY INC. BTCY

0001641172-25-023709

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Aug 13, 2025 26.57M sh
Shares Diluted Q1 2026 · Jun 30, 2025 26.28M sh
Shares Diluted Q1 2026 · Jun 30, 2024 14.17M sh
Operating Cash Flow Q1 2026 · Jun 30, 2025 −$373.39K
Operating Cash Flow Q1 2026 · Jun 30, 2024 −$1.49M
Cash And Equivalents Q1 2026 · Jun 30, 2025 $391.29K
Cash And Equivalents Q1 2026 · Mar 31, 2025 $365.15K
Stockholders Equity Q1 2026 · Jun 30, 2025 −$32.8M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$32.01M
Stockholders Equity Q1 2026 · Jun 30, 2024 −$29.78M
Stockholders Equity Q1 2026 · Mar 31, 2024 −$31.47M
Current Liabilities Q1 2026 · Jun 30, 2025 $21.81M
Current Liabilities Q1 2026 · Mar 31, 2025 $20.64M
Total Liabilities Q1 2026 · Jun 30, 2025 $36.84M
Total Liabilities Q1 2026 · Mar 31, 2025 $35.66M
Current Assets Q1 2026 · Jun 30, 2025 $5.14M
Current Assets Q1 2026 · Mar 31, 2025 $4.64M
Total Assets Q1 2026 · Jun 30, 2025 $6.04M
Total Assets Q1 2026 · Mar 31, 2025 $5.64M
Eps Diluted Q1 2026 · Jun 30, 2025 −$0.03
Eps Diluted Q1 2026 · Jun 30, 2024 −$0.49
Eps Basic Q1 2026 · Jun 30, 2025 −$0.03
Eps Basic Q1 2026 · Jun 30, 2024 −$0.49
Sga Expense Q1 2026 · Jun 30, 2025 $2.14M
Sga Expense Q1 2026 · Jun 30, 2024 $2.97M
Rd Expense Q1 2026 · Jun 30, 2025 $696.16K
Rd Expense Q1 2026 · Jun 30, 2024 $513.9K
Net Income Q1 2026 · Jun 30, 2025 −$671.98K
Net Income Q1 2026 · Jun 30, 2024 −$3.69M
Operating Income Q1 2026 · Jun 30, 2025 $281.95K
Operating Income Q1 2026 · Jun 30, 2024 −$1.12M
Gross Profit Q1 2026 · Jun 30, 2025 $3.12M
Gross Profit Q1 2026 · Jun 30, 2024 $2.36M
Cost Of Revenue Q1 2026 · Jun 30, 2025 $757.19K
Cost Of Revenue Q1 2026 · Jun 30, 2024 $838.58K
Revenue Q1 2026 · Jun 30, 2025 $3.87M
Revenue Q1 2026 · Jun 30, 2024 $3.2M